Fortrea is a global contract research organization (CRO) specializing in clinical development and patient access solutions for the biopharmaceutical industry. Headquartered in Durham, North Carolina, the company was spun off from Labcorp in 2023, inheriting decades of expertise in drug development services. Fortrea’s mission is to accelerate the delivery of life-changing therapies to patients worldwide by providing comprehensive Phase I-IV clinical trial management, regulatory support, and market access strategies.

With a workforce of approximately 19,000 employees operating in more than 90 countries, Fortrea serves a diverse range of clients, from emerging biotech firms to large pharmaceutical companies. The organization is recognized for its robust global infrastructure, deep therapeutic expertise, and commitment to innovation in clinical trial design and execution. Since its launch as an independent company, Fortrea has focused on expanding its capabilities, forging strategic partnerships, and leveraging advanced technologies to improve trial efficiency and patient outcomes. In recent news, Fortrea has been actively positioning itself as a leading pure-play CRO, aiming to capture market share in a rapidly evolving life sciences landscape.